Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP. Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) for Clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network and Orofacial Pain Special Interest Group. J Oral Facial Pain Headache. 2014;28(1):6-27.

Okeson JP. Joint intracapsular disorders: diagnostic and nonsurgical management considerations. Dent Clin North Am. 2007;51(1):85-103.

Wadhwa S, Kapila S. TMJ disorders: future innovations in diagnostics and therapeutics. J Dent Educ. 2008;72(8):930-47.

Manfredini D, Guarda-Nardini L, Winocur E, Piccotti F, Ahlberg J, Lobbezoo F. Research diagnostic criteria for temporomandibular disorders: a systematic review of axis I epidemiologic findings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011;112(4):453-62.

Carrara SV, Conti PC, Barbosa JS. Termo do 1º Consenso em Disfunção Temporomandibular e Dor Orofacial. Dental Press J Orthod. 2010;15(3):114-20.

Young AL. Internal derangements of the temporomandibular joint: a review of the anatomy, diagnosis, and management. J Indian Prosthodont Soc. 2015;15(1):2-7.

Brunton LL, Chabner BA, Knollman BA. As Bases Farmacológicas da Terapêutica de Goodman e Gilman. 2012:563-600.

Consolaro A. Inflamação e Reparo. 2015:63-120.

Rahmati M, Mobasheri A, Mozafari M. Inflammatory mediators in osteoarthritis: a critical review of the state-of-the art, current prospects, and future challenges. Bone. 2016:81-90.

Bouloux GF. Temporomandibular joint pain and synovial fluid analysis: a review of the literature. J Oral Maxillofac Surg. 2009;67(11):2497-504.

Ernberg M. The role of molecular pain biomarkers in temporomandibular joint internal derangement. J Oral Rehabil. 2017;44(6):481-91.

Wieckiewicz M, Boening K, Wiland P, Shiau YY, Paradowska-Stolarz A. Reported concepts for the treatment modalities and pain management of temporomandibular disorders. J Headache Pain. 2015;16:106.

Hosgor H, Bas B, Celenk C. A comparison of the outcomes of four minimally invasive treatment methods for anterior disc displacement of the temporomandibular joint. Int J Oral Maxillofac Surg. 2017;46(11):1403-10.

Okeson JP. Tratamento das desordens temporomandibulares e oclusão. 2013:154-5.

Valle RT, Grossmann E, Fernandes RSM. Disfunções Temporomandibulares: Abordagem Clínica. 2015:80-102.

Gynther GW, Dijkgraaf LC, Reinholt FP, Holmlund AB, Liem RS, de Bont LG. Synovial inflammation in arthroscopically obtained biopsy specimens from the temporomandibular joint: a review of the literature and a proposed histologic grading system. J Oral Maxillofac Surg. 1998;56(11):1281-6.

Israel HA. Internal derangement of the temporomandibular joint: new perspectives on an old problem. Oral Maxillofac Surg Clin North Am. 2016;28(3):313-33.

de Bont LG, Dijkgraaf LC, Stegenga B. Epidemiology and natural progression of articular temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1997;83(1):72-6.

Oliveira Junior JO, Portella Junior CS, Cohen CP. Inflammatory mediators of neuropathic pain. Rev Dor. 2016;17(Suppl 1):35-42.

Yagiela JA, Dowd FJ, Johnson B, Mariotti A. Farmacologia e Terapêutica para Dentistas. 2011:318-52.

Henry CH, Wolford LM. Substance P and mast cells: preliminary histologic analysis of the human temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001;92(4):384-9.

Li W, Long X, Jiang S, Li Y, Fang W. Histamine and substance P in synovial fluid of patients with temporomandibular disorders. J Oral Rehabil. 2015;42(5):363-9.

Ting E, Roveroni RC, Ferrari LF, Lotufo CM, Veiga MC, Parada CA. Indirect mechanism of histamine-induced nociception in temporomandibular joint of rats. Life Sci. 2007;81(9):765-71.

Wannamacher L, Ferreira MBC. Farmacologia Clínica para Dentistas. 2007:129-43.

Alstergren P, Kopp S. Pain and synovial fluid concentration of serotonin in arthritic temporomandibular joints. Pain. 1997;72(2):137-43.

Oliveira-Fusaro MC, Clemente-Napimoga JT, Teixeira JM, Torres-Chávez KE, Parada CA, Tambeli CH. 5-HT induces temporomandibular joint nociception in rats through the local release of inflammatory mediators and activation of local b adrenoceptors. Pharmacol Biochem Behav. 2012;102(3):458-64.

Suzuki T, Segami N, Nishimura M, Sato J, Nojima T. Bradykinin expression in synovial tissues and synovial fluids obtained from patients with internal derangement of the temporomandibular joint. Cranio. 2003;21(4):265-70.

Kaneyama K, Segami N, Sato J, Fujimura K, Nagao T, Yoshimura H. Prognostic factors in arthrocentesis of the temporomandibular joint: comparison of bradykinin, leukotriene B4, prostaglandin E2, and substance P level in synovial fluid between successful and unsuccessful cases. J Oral Maxillofac Surg. 2007;65(2):242-7.

Nishimura M, Segami N, Kaneyama K, Suzuki T, Miyamaru M. Relationships between pain-related mediators and both synovitis and joint pain in patients with internal derangements and osteoarthritis of the temporomandibular joint. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;94(3):328-32.

Alstergren P, Kopp S. Prostaglandin E2 in temporomandibular joint synovial fluid and its relation to pain and inflammatory disorders. J Oral Maxillofac Surg. 2000;58(2):180-6.

Zhang P, Gan YH. Prostaglandin E2 upregulated trigeminal ganglionic sodium channel 1.7 involving temporomandibular joint inflammatory pain in rats. Inflammation. 2017;40(3):1102-9.

Quinn JH, Bazan NG. Identification of prostaglandin E2 and leukotriene B4 in the synovial fluid of painful, dysfunctional temporomandibular joints. J Oral Maxillofac Surg. 1990;48(9):968-71.

Schütz TC, Andersen ML, Tufik S. Influence of temporomandibular joint pain on sleep patterns: role of nitric oxide. J Dent Res. 2004;83(9):693-7.

Güven O, Tozoglu S, Tekin U, Salmanoglu B, Günes O. Relationship between activity of gluthatione peroxidase and nitric oxide in synovial fluid and the progression of temporomandibular joint internal derangement. J Craniofac Surg. 2015;26(3):e210-3.

de Oliveira CM, Sakata RK, Issy AM, Gerola LR, Salomão R. Cytokines and pain. Rev Bras Anestesiol. 2011;61(2):255-65.

Kaneyama K, Segami N, Sun W, Sato J, Fujimura K. Levels of soluble cytokine factors in temporomandibular joint effusions seen on magnetic resonance images. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2005;99(4):411-8.

Kellesarian SV, Al-Kheraif AA, Vohra F, Ghanem A, Malmstrom H, Romanos GE. Cytokine profile in the synovial fluid of patients with temporomandibular joint disorders: a systematic review. Cytokine. 2016;77:98-106.

Curfs JH, Meis JF, Hoogkamp-Korstanje JA. A primer on cytokines: sources, receptors, effects, and inducers. Clin Microbiol Rev. 1997;10(4):742-80.

Raeburn CD, Sheppard F, Barsness KA, Arya J, Harken AH. Cytokines for surgeons. Am J Surg. 2002;183(3):268-73.

Furquim BD, Flamengui LM, Repeke CE, Cavalla F, Garlet GP, Conti PC. Influence of TNF-a-308 G/A gene polymorphism on temporomandibular disorder. Am J Orthod Dentofacial Orthop. 2016;149(5):692-8.

Taylor PC, Williams RO, Feldmann M. Tumour necrosis factor alpha as a therapeutic target for immune-mediated inflammatory diseases. Curr Opin Biotechnol. 2004;15(6):557-63.

Fredriksson L, Alstergren P, Kopp S. Tumor necrosis factor-alpha in temporomandibular joint synovial fluid predicts treatment effects on pain by intra-articular glucocorticoid treatment. Mediators Inflamm. 2006;2006(6):59425.

Ahmed N, Petersson A, Catrina AI, Mustafa H, Alstergren P. Tumor necrosis factor mediates temporomandibular joint bone tissue resorption in rheumatoid arthritis. Acta Odontol Scand. 2015;73(3):232-40.

Contassot E, Beer HD, French LE. Interleukin-1, inflammasomes, autoinflammation and the skin. Swiss Med Wkly. 2012;142:w13590.

Tominaga K, Habu M, Sukedai M, Hirota Y, Takahashi T, Fukuda J. IL-1 beta, IL-1 receptor antagonist and soluble type II IL-1 receptor in synovial fluid of patients with temporomandibular disorders. Arch Oral Biol. 2004;49(6):493-9.

Sorenson A, Hresko K, Butcher S, Pierce S, Tramontina V, Leonardi R. Expression of Interleukin-1 and temporomandibular disorder: contemporary review of the literature. Cranio. 2017;19:1-5.

Nishimoto N, Kishimoto T, Yoshizaki K. Anti-interleukin 6 receptor antibody treatment in rheumatic disease. Ann Rheum Dis. 2000;59(Suppl 1):i21-7.

Gunson MJ, Arnett GW, Milam SB. Pathophysiology and pharmacologic control of osseous mandibular condylar resorption. J Oral Maxillofac Surg. 2012;70(8):1918-34.

Sato J, Segami N, Nishimura M, Demura N, Yoshimura H, Yoshitake Y. Expression of interleukin 6 in synovial tissues in patients with internal derangement of the temporomandibular joint. Br J Oral Maxillofac Surg. 2003;41(2):95-101.

Fu K, Ma X, Zhang Z, Pang X, Chen W. Interleukin-6 in synovial fluid and HLADR expression in synovium from patients with temporomandibular disorders. J Orofac Pain. 1995;9(2):131-7.

Lin E, Calvano SE, Lowry SF. Inflammatory cytokines and cell response in surgery. Surgery,. 2000;127(2):117-26.

Kaplanski G, Marin V, Montero-Julian F, Mantovani A, Farnarier C. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation. Trends Immunol. 2003;24(1):25-9.

Yamamoto M, Yoshizaki K, Kishimoto T, Ito H. IL-6 is required for the development of Th-1 cell-mediated murine colitis. J Immunol. 2000;164(9):4878-82.

Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G. Interleukin-6 is required for the development of collagen induced arthritis. J Exp Med. 1998;187(4):461-8.

Gunson MJ, Arnett GW, Milam SB. Pathophysiology and pharmacologic control of osseous mandibular condylar resorption. J Oral Maxillofac Surg. 2012;70(8):1918-34.

De Alcântara Camejo F, Azevedo M, Ambros V, Caporal KST, Doetzer AD, Almeida LE. Interleukin-6 expression in disc derangement of human temporomandibular joint and association with osteoarthrosis. J Craniomaxillofac Surg. 2017;45(5):768-74.